๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Reimbursement issues in cancer clinical trials

โœ Scribed by Robert J. McKenna


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
225 KB
Volume
65
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Clinical trials in testicular cancer
โœ Charles F. Kettering Prize; Lawrence H. Einhorn ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 289 KB ๐Ÿ‘ 1 views
Interpreting cancer vaccine clinical tri
โœ Glenn Dranoff ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 53 KB ๐Ÿ‘ 1 views

A number of cancer vaccine strategies have entered initial Phase I clinical testing. In this review, Dr. Glenn Dranoff discusses the prospects that appropriate immunologic monitoring of patients in these trials can help delineate important differences among the various immunization strategies and pr

Practical issues in equivalence trials
โœ A. F. Ebbutt; L. Frith ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 81 KB ๐Ÿ‘ 1 views

Equivalence trials aim to show that two treatments have equivalent therapeutic effects. The approach is to define, in advance, a range of equivalence !d to#d for the treatment difference such that any value in the range is clinically unimportant. If the confidence interval for the difference, calcul

Attitudes in clinical trials
โœ Peter Armitage ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 74 KB ๐Ÿ‘ 1 views

Two important papers by Schwartz and Lellouch have drawn distinctions between explanatory and pragmatic attitudes to clinical trials, and between individual and collective ethics. The pragmatic approach accords with the widespread use of 'intention-to-treat' analyses, but recent research has started